Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin

Jul-12

Endocrinology Pharmacoepidemiology

AUTHORS : Betina Blak (Details for study: Cegedim Strategic Data Medical Research Ltd) now works at AstraZeneca, Horizon Place, 600 Capability Green, Luton, Bedfordshire LU1 3LU, UK – Email: betina.blak@astrazeneca.com

JOURNAL : Diabetic Medicine

REFERENCE: 29(7):e13-20

DOI : 10.1111/j.1464-5491.2012.03586.x

Read more